{"id":"https://openalex.org/W2188184938","doi":null,"title":"Antitumor Activityof N-(Phosphonacetyl)-L-asparticAcid, a Transition-StateInhibitorof Aspartate Transcarbamylase","display_name":"Antitumor Activityof N-(Phosphonacetyl)-L-asparticAcid, a Transition-StateInhibitorof Aspartate Transcarbamylase","publication_year":1976,"publication_date":"1976-01-01","ids":{"openalex":"https://openalex.org/W2188184938","mag":"2188184938"},"language":"en","primary_location":{"id":"mag:2188184938","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/36/8/2720.full.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103465098","display_name":"Randall K. Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Randall K. Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111811656","display_name":"ABRAHAM S. GOLDIN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abraham Goldin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5080998429","display_name":"George Robert Stark","orcid":"https://orcid.org/0000-0002-8776-9597","observed_orcids":["https://orcid.org/0000-0002-8776-9597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George R. Stark","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8776-9597","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12859691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-phosphonacetyl-l-aspartate","display_name":"N-(phosphonacetyl)-L-aspartate","score":0.9760000109672546},{"id":"https://openalex.org/keywords/pala","display_name":"PALA","score":0.7379999756813049},{"id":"https://openalex.org/keywords/aspartate-transcarbamoylase","display_name":"aspartate transcarbamylase","score":0.9049999713897705},{"id":"https://openalex.org/keywords/transition-state-analogue-inhibitors","display_name":"transition-state inhibitors","score":0.7900000214576721},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8889999985694885},{"id":"https://openalex.org/keywords/pyrimidine-biosynthesis","display_name":"pyrimidine synthesis","score":0.7960000038146973},{"id":"https://openalex.org/keywords/antimetabolites","display_name":"antimetabolites","score":0.8970000147819519},{"id":"https://openalex.org/keywords/lewis-lung-carcinoma","display_name":"Lewis lung carcinoma","score":0.7689999938011169},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9629999995231628},{"id":"https://openalex.org/keywords/p388-leukemia","display_name":"P388 leukemia","score":0.9549999833106995},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.9559999704360962},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.824999988079071},{"id":"https://openalex.org/keywords/transplantable-tumors","display_name":"transplantable tumors","score":0.7730000019073486},{"id":"https://openalex.org/keywords/prolonged-survival","display_name":"survival prolongation","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C2777847059","wikidata":"https://www.wikidata.org/wiki/Q6537255","display_name":"Lewis lung carcinoma","level":4,"score":0.9318965673446655},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.603691577911377},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5516449809074402},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.517565906047821},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.4766600728034973},{"id":"https://openalex.org/C2780635560","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Neoplasm","level":2,"score":0.47227391600608826},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.43644073605537415},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3952053189277649},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32987621426582336},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32071536779403687},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2674659490585327},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21195745468139648},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.07364919781684875}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188184938","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/36/8/2720.full.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1480437404","https://openalex.org/W1561167748","https://openalex.org/W1581160821","https://openalex.org/W1658317722","https://openalex.org/W1976287604","https://openalex.org/W2034627702","https://openalex.org/W2044546705","https://openalex.org/W2075430955","https://openalex.org/W2081877434","https://openalex.org/W2237040806","https://openalex.org/W2414910954","https://openalex.org/W2416741417"],"related_works":["https://openalex.org/W2138948753","https://openalex.org/W1480437404","https://openalex.org/W156275343","https://openalex.org/W1658317722","https://openalex.org/W1996935259","https://openalex.org/W1548929804","https://openalex.org/W1519003385","https://openalex.org/W2415530480","https://openalex.org/W2419527040","https://openalex.org/W2114605359"],"abstract_inverted_index":{"SUMMARY":[0],"N-(Phosphonacetyl)-L-aspartate":[1],"(PALA)":[2],"is":[3,36,80],"an":[4],"analog":[5],"of":[6,28,105,114,132,186,194,224,229],"the":[7,11,103,195,214],"transition":[8],"state":[9],"for":[10],"aspartate":[12],"transcarbamylase":[13],"reac":[14],"tion":[15],"and":[16,25,69,157,181,227],"has":[17,41],"been":[18],"reported":[19],"previously":[20],"to":[21,82,91,127,141,165,174,192],"be":[22],"a":[23,130,162],"potent":[24],"specific":[26],"inhibitor":[27],"de":[29],"novo":[30],"pyrimidine":[31],"nucleotide":[32],"biosyn":[33],"thesis.":[34],"It":[35],"now":[37],"shown":[38],"that":[39],"PALA":[40,98,123,150,211],"considerable":[42],"antitu":[43],"mor":[44],"activity":[45],"against":[46,59,63],"certain":[47],"transplantable":[48],"tumors":[49,205],"in":[50],"mice.":[51,196],"PALA,":[52],"unlike":[53],"other":[54],"antimetabolites,":[55],"was":[56,120,171,190,199],"less":[57],"effective":[58],"ascitic":[60],"leukemias":[61],"than":[62,144],"two":[64],"solid":[65,74],"tumors,":[66],"616":[67],"melanoma":[68,138],"Lewis":[70,159,187,203],"lung":[71,160,188,204],"carcinoma.":[72],"Another":[73],"tumor,":[75],"Ridgway":[76],"osteogenic":[77],"sarcoma,":[78],"which":[79],"sensitive":[81,173],"many":[83],"established":[84],"chemotherapeutic":[85],"agents,":[86,170],"did":[87,99,145],"not":[88,100],"re":[89],"spond":[90],"PALA.":[92,175],"Daily":[93],"or":[94],"intermittent":[95],"treatment":[96,124,198],"with":[97,149],"significantly":[101],"increase":[102],"life-span":[104],"mice":[106,115,134,215],"bearing":[107,116,135],"i.p.":[108,117,136],"leukemia":[109,119],"L1210.":[110],"The":[111],"survival":[112,230],"time":[113],"P388":[118],"prolonged":[121],"by":[122,125],"up":[126],"64%.":[128],"In":[129],"number":[131],"experiments":[133],"B16":[137],"survived":[139],"77":[140],"86%":[142],"longer":[143],"controls":[146],"when":[147],"treated":[148],"(490":[151],"mg/kg)":[152],"on":[153,177],"Days":[154,178],"1,":[155,179],"5,":[156,180],"9.":[158],"carcinoma,":[161],"tumor":[163,219,225],"refractory":[164],"most":[166],"estab":[167],"lished":[168],"antineoplastic":[169],"highly":[172],"Treatment":[176],"9":[182],"following":[183],"s.c.":[184,202],"implantation":[185],"carcinoma":[189],"curative":[191],"50%":[193],"If":[197],"delayed":[200],"until":[201],"had":[206],"reached":[207],"about":[208],"500":[209],"mg,":[210],"neither":[212],"cured":[213],"nor":[216],"produced":[217],"significant":[218],"regression.":[220],"However,":[221],"extensive":[222],"delay":[223],"growth":[226],"prolongation":[228],"were":[231],"still":[232],"observed.":[233]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}